A Shigella Vaccine Against Prevalent Serotypes

被引：7
|
作者：
Van de Verg, Lillian L. [1 ]
Venkatesan, Malabi M. [2 ]
机构：
[1] PATH, Vaccine Dev Global Program, Washington, DC 20001 USA
[2] Walter Reed Army Inst Res, Bacterial Dis Branch, Silver Spring, MD USA
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 59卷 / 07期
关键词：
Shigella; vaccine; O-antigen; cross-reactivity; prevalence; FLEXNERI O-ANTIGENS; CHILDREN; MULTICENTER; PROTECTION; RESISTANCE; COUNTRIES; STRAINS; DISEASE; BURDEN;
D O I：
10.1093/cid/ciu471
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：942 / 943
页数：2
相关论文
共 50 条
  • [41] Characterization of Salmonella serotypes prevalent in asymptomatic people and patients
    Xu, Haiyan
    Zhang, Weibing
    Zhang, Kai
    Zhang, Yue
    Wang, Zhenyu
    Zhang, Wei
    Li, Yang
    Li, Qiuchun
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [42] Comparative immunosecretome analysis of prevalent Streptococcus suis serotypes
    Gomez-Gascon, Lidia
    Luque, Inmaculada
    Tarradas, Carmen
    Olaya-Abril, Alfonso
    Astorga, Rafael J.
    Huerta, Belen
    Rodriguez-Ortega, Manuel J.
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2018, 57 : 55 - 61
  • [43] Characterization of Salmonella serotypes prevalent in asymptomatic people and patients
    Haiyan Xu
    Weibing Zhang
    Kai Zhang
    Yue Zhang
    Zhenyu Wang
    Wei Zhang
    Yang Li
    Qiuchun Li
    BMC Infectious Diseases, 21
  • [44] A SURVEY OF STREPTOCOCCUS-SUIS SEROTYPES PREVALENT IN THE MIDWEST
    COBB, SG
    WILKINS, LM
    AGRI-PRACTICE, 1989, 10 (01): : 2 - 2
  • [45] The search for an efficacious shigella vaccine
    Wierzba, Thomas F.
    LANCET INFECTIOUS DISEASES, 2021, 21 (04): : 446 - 447
  • [46] Progress in Shigella vaccine development
    Kotloff, KL
    VACCINES: PREVENTING DISEASE AND PROTECTING HEALTH, 2004, (596): : 130 - 139
  • [47] Shigella Sonnei vaccine.
    不详
    Drugs in R & D, 1999, 2 (3) : 222 - 223
  • [48] Universal dengue virus DNA vaccine elicits immune responses against all serotypes
    不详
    EXPERT REVIEW OF VACCINES, 2009, 8 (09) : 1136 - 1136
  • [49] Vaccine value profile for Shigella
    Hausdorff, William P.
    Anderson, John D.
    Bagamian, Karoun H.
    Bourgeois, A. Louis
    Mills, Melody
    Sawe, Frederick
    Scheele, Suzanne
    Talaat, Kawsar
    Giersing, Birgitte K.
    VACCINE, 2023, 41 : S76 - S94
  • [50] Frontiers in Shigella Vaccine Development
    MacLennan, Calman Alexander
    Steele, Andrew Duncan
    VACCINES, 2022, 10 (09)
12345